A six-month randomized controlled trial examined whether 1.15 grams daily of whole fruit feijoa powder could enhance metabolic benefits of weight loss in 97 overweight adults with prediabetes. While feijoa supplementation showed no additional benefits for weight loss or fasting glucose compared to placebo, it significantly reduced systolic blood pressure by months four and six of the intervention. The researchers attribute this cardiovascular benefit to feijoa's rich polyphenolic profile, particularly its high catechin content. This finding adds to mounting evidence that specific fruit polyphenols may offer targeted health benefits beyond their sugar and fiber content. The blood pressure reduction is particularly relevant for prediabetic populations, who face elevated cardiovascular disease risk alongside their diabetes progression risk. However, the study's modest effect size and relatively small sample limit broader conclusions about feijoa's therapeutic potential. Additionally, this preprint awaits peer review, so these results require validation before clinical recommendations. The research represents an incremental advance in understanding how specific fruit bioactives might complement lifestyle interventions for metabolic health, though larger studies are needed to establish clinical significance.